Neutropenia
Key points
- Neutropenia occurs in the HIV-infected patient in concert with decreases in other cell counts with progressive deterioration of the immune system.
- Neutropenia is most commonly caused by myelosuppressive therapy in AIDS patients.
- In addition to neutropenia, neutrophil dysfunction has been reported in AIDS.
- The extent to which neutrophil defects, particularly of microbial killing, contribute to host immune impairment is unknown.
Neutropenia occurs in the HIV-infected patient in concert with decreases in other cell counts with progressive deterioration of the immune system. In addition to neutropenia, neutrophil dysfunction has been reported in AIDS. The extent to which neutrophil defects, particularly of microbial killing, contribute to host immune impairment is unknown.
Neutropenia is most commonly caused by myelosuppressive therapy in AIDS patients. AZT treatment is at times limited by neutropenia, although other antiretrovirals do not seem to cause this problem. Other therapies, including trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia, pyrimethamine-sulfadiazine for central nervous system (CNS) toxoplasmosis, acyclovir for disseminated herpes simplex or herpes zoster, and most prominently ganciclovir for CMV retinitis may be myelotoxic and result in neutropenia.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsScreening in pregnancy key to eliminating mother-to-child HIV transmission
Canada has almost eliminated mother-to-child HIV transmission, known as vertical transmission, in recent years by ensuring that all women have the opportunity to be screened for HIV in pregnancy and that women with the…
23 July 2015
NewsCholesterol metabolism in immune cells linked to HIV progression
Lower levels of cholesterol in certain immune cells - a result of enhanced cholesterol metabolism within those cells - may help explain why some HIV-infected people are able to naturally control disease progression,…
21 July 2015
NewsNew understanding of genetic susceptibility to infections by Candida and Mycobacterium
The discovery of bi-allelic mutations in RORC in patients with candidiasis and mycobacteriosis revealed the pivotal role of RORC in mucocutaneous immunity to Candida and in systemic immunity to Mycobacterium in humans.…
